A potassium phosphate, monobasic CEP of the European Pharmacopoeia monograph is often referred to as a potassium phosphate, monobasic Certificate of Suitability (COS). The purpose of a potassium phosphate, monobasic CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of potassium phosphate, monobasic EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of potassium phosphate, monobasic to their clients by showing that a potassium phosphate, monobasic CEP has been issued for it. The manufacturer submits a potassium phosphate, monobasic CEP (COS) as part of the market authorization procedure, and it takes on the role of a potassium phosphate, monobasic CEP holder for the record. Additionally, the data presented in the potassium phosphate, monobasic CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the potassium phosphate, monobasic DMF.
A potassium phosphate, monobasic CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. potassium phosphate, monobasic CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of potassium phosphate, monobasic suppliers with CEP (COS) on PharmaCompass.